Exclusive: Merida Biosciences gets $121M to treat autoimmune and allergy diseases at their roots
A scrappy team of drug developers has come together to create new medicines for patients with autoimmune diseases and allergies. They're going after the bustling subfield of Graves' disease and also aiming to take on ...
